Literature DB >> 33434363

Immune Checkpoint Inhibitors in Combinations for Hepatocellular Carcinoma.

Sharanya Maanasi Kalasekar1, Ignacio Garrido-Laguna1,2, Kimberley Jane Evason1,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33434363     DOI: 10.1002/hep.31706

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  5 in total

1.  Relationships Between Indices of Tumor Aggressiveness in Hepatocellular Carcinoma.

Authors:  Brian I Carr; Vito Guerra; Rossella Donghia; Seai Yilmaz
Journal:  J Gastrointest Cancer       Date:  2021-10-06

2.  Hepatic Tumor Stiffness Measured by Shear Wave Elastography Is Prognostic for HCC Progression Following Treatment With Anti-PD-1 Antibodies Plus Lenvatinib: A Retrospective Analysis of Two Independent Cohorts.

Authors:  Guosheng Yuan; Fuli Xie; Yangda Song; Qi Li; Rong Li; Xiaoyun Hu; Mengya Zang; Xiao Cheng; Guanting Lu; Jing Huang; Wenzhe Fan; Xiaoxiang Rong; Jian Sun; Jinzhang Chen
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

3.  Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.

Authors:  Jianjun Xu; Qichang Zheng; Xiang Cheng; Shaobo Hu; Chen Zhang; Xing Zhou; Ping Sun; Weimin Wang; Zhe Su; Tianhao Zou; Zifang Song; Yun Xia; Xiaoqing Yi; Yang Gao
Journal:  J Nanobiotechnology       Date:  2021-10-30       Impact factor: 10.435

4.  Prognostic Role and Potential Mechanisms of N6-methyladenosine-related Long Noncoding RNAs in Hepatocellular Carcinoma.

Authors:  Tianxing Dai; Jing Li; Linsen Ye; Haoyuan Yu; Mingbin Deng; Wei Liu; Hua Li; Yang Yang; Guoying Wang
Journal:  J Clin Transl Hepatol       Date:  2021-07-13

5.  A novel cuproptosis-related prognostic lncRNA signature for predicting immune and drug therapy response in hepatocellular carcinoma.

Authors:  Shujia Chen; Peiyan Liu; Lili Zhao; Ping Han; Jie Liu; Hang Yang; Jia Li
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.